checkAd
    Startseite > Aktien > BioVie Registered (A) > Nachrichten
    BioVie Registered (A) Aktie
    0,4874
     
    USD
    -2,03 %
    -0,0101 USD
    Letzter Kurs 02:00:00 NYSE
    0,4850
     
    USD
    100 STK
    Geldkurs 10.05.24
    0,4974
     
    USD
    400 STK
    Briefkurs 10.05.24
    ISIN: US09074F2074 · WKN: A2PVAH · SYM: BIVI · USA

    Neueste Nachrichten

    BioVie Awarded up to $13.1 Million in Funding from U.S. Department of Defense to Evaluate Bezisterim (NE3107) for the Treatment of Long COVID
    29.04.24 · globenewswire · BioVie Registered (A)
    BioVie Presents Data Showing Potential for Bezisterim (NE3107) to Reduce Inflammation and Restore Homeostasis in a Manner Correlated with Alzheimer’s Disease and Biomarker Endpoints
    25.04.24 · globenewswire · BioVie Registered (A)
    BioVie to Present Data Showing How NE3107 Potentially Restores Homeostasis via Specific Genes Associated with Dementia, Metabolism, and Inflammation
    18.04.24 · globenewswire · BioVie Registered (A)
    The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against BioVie Inc. (BIVI)
    18.03.24 · Business Wire (engl.) · BioVie Registered (A)
    BioVie Announces Pipeline Update and Near-Term Clinical Priorities
    11.03.24 · globenewswire · BioVie Registered (A)
    BioVie Inc. Announces Closing of Public Offering
    06.03.24 · globenewswire · BioVie Registered (A)
    BioVie Inc. Announces Pricing of Public Offering
    04.03.24 · globenewswire · BioVie Registered (A)
    BioVie Inc. Announces Proposed Public Offering of Common Stock
    01.03.24 · globenewswire · BioVie Registered (A)
    BioVie Inc. Announces Proposed Public Offering of Common Stoc
    01.03.24 · globenewswire · BioVie Registered (A)
    BioVie’s NE3107 Demonstrates Potential Improvements in Motor and Non-motor Symptoms for Parkinson’s Disease Patients and May Be Realigning Physiological Processes for Alzheimer’s Patients in Data to be Presented at the International Conference on Alzheime
    01.03.24 · globenewswire · BioVie Registered (A)
    BIOVIE INVESTOR ALERT: Kirby McInerney LLP Notifies BioVie, Inc. (BIVI) Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit
    12.02.24 · Business Wire (engl.) · BioVie Registered (A)
    BioVie to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
    06.02.24 · globenewswire · BioVie Registered (A)